Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01388
http://purl.obolibrary.org/obo/dinto_DB01388
|
|---|---|
| Preferred Name | mibefradil |
| Synonyms |
C29H38FN3O3
(1S,2S)-2-(2-{[3-(1H-1,3-benzodiazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetate
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | mibefradil
|
|---|---|
| label | mibefradil
|
| ATCCode | C08CX01
|
| Definition | Mibefradil was withdrawn from the market in 1998 because of potentially harmful interactions with other drugs.
|
| has pharmacological target |
See more
See less
|
| inhibits |
See more
See less
|
| type | |
| InChIKey | InChIKey=HBNPJJILLOYFJU-VMPREFPWSA-N
|
| is metabolised by | |
| Synonym | C29H38FN3O3
(1S,2S)-2-(2-{[3-(1H-1,3-benzodiazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetate
|
| xref |
PubChem Substance:46504498
PubChem Compound:60663
PharmGKB:PA450492
Wikipedia:http://en.wikipedia.org/wiki/Mibefradil
BindingDB:50117922
ChemSpider:54673
See more
See less
|
| CASRN | 116644-53-2
|
| prefixIRI | obo2:dinto_DB01388
|
| SMILES | COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
|
| may interact with | |
| InChI | InChI=1S/C29H38FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32)/t28-,29-/m0/s1
|
| DBBrand | posicor
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |